mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.8 |